Conditions: Asthma
Keywords: Asthma AMP Ciclesonide Fluticasone propionate
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 37
Healthy volunteers: no

Brief summary:
The aim of this study is to compare the responsiveness of lower airways in adult patients with stable asthma after treatment with ciclesonide and fluticasone propionate. Treatment medication will be administered as follows: ciclesonide will be inhaled once daily at one dose level, fluticasone propionate will be inhaled twice daily at one dose level. The study duration consists of a baseline period (5 weeks) and a treatment period (5 weeks). The study will provide further data on safety and tolerability of ciclesonide.

Detailed description:

Arms:
arm 1: Ciclesonide 160 µg arm 2: Fluticasone 100 µg

Interventions: intervention 1: Ciclesonide intervention 2: Fluticasone
Intervention descriptions: intervention 1: inhaled Ciclesonide 160 µg, once daily in the morning intervention 2: inhaled Fluticasone 100 µg, twice daily

Protocol document: